Jianzhijia Pharmaceutical Hits Day Low at CNY 17.80 Amid Price Pressure

Jianzhijia Pharmaceutical Chain Group Co. experienced significant activity on March 23, 2026, with the stock declining by 7.08% and reaching an intraday low of CNY 17.80. This performance marks a stark contrast to the broader market, as the China Shanghai Composite index fell by only 3.63% on the same day. Over the past week, Jianzhijia has seen a decline of 11.3%, and its one-month performance reflects a drop of 12.16%. Year-to-date, the stock has decreased by 6.45%, while its one-year performance shows a notable decline of 17.64%. The three-year and five-year performance figures are particularly concerning, with losses of 66.21% and 55.82%, respectively. Financial metrics indicate challenges for Jianzhijia, including a high debt-equity ratio of 167.92% and a low interest coverage ratio of 248.95. The company's return on equity stands at 5.37%, and it has reported negative results for six consecutive quarters. These factors contribute to a challenging market position for the small-cap retailing company.